Actionable news
All posts from Actionable news
Actionable news in ONCY: Oncolytics Biotech, Inc.,

Media Advisory - Oncolytics Biotech® Inc. to Participate in the 14th Annual BIO Investor Forum

Oncolytics' Reolysin Phase II Lung Cancer Study Enrolled

CALGARY, Oct. 20, 2015 /PRNewswire/ - Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY), will participate in the 14th Annual BIO Investor Forum in a session on Wednesday, October 21st, 2015 at 10:30 a.m. PT (1:30 p.m. ET). The event takes place on October 20th and 21st at the Parc 55 Hotel in San Francisco, CA.

A live audio link to the webcast session will be available at: or on the company's website at It is recommended that listeners log on 10 minutes in advance of a live session to register and...